OIERX
Price
$28.23
Change
+$0.31 (+1.11%)
Updated
Jul 2 closing price
Net Assets
44.15B
RMEBX
Price
$64.30
Change
+$0.40 (+0.63%)
Updated
Jul 2 closing price
Net Assets
116.64B
Interact to see
Advertisement

OIERX vs RMEBX

OIERX vs RMEBX Comparison Chart in %
View a ticker or compare two or three
VS
OIERX vs. RMEBX commentary
Jul 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OIERX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 117B vs. OIERX (44.2B). OIERX pays higher dividends than RMEBX: OIERX (1.47) vs RMEBX (1.00). OIERX was incepted earlier than RMEBX: OIERX (15 years) vs RMEBX (12 years). RMEBX (1.07) is less costly to investors than OIERX (0.55). RMEBX is a more actively managed with annual turnover of: 30.00 vs. OIERX (20.00). OIERX has a lower initial minimum investment than RMEBX: OIERX (0) vs RMEBX (250). OIERX annual gain was more profitable for investors over the last year : 12.25 vs. RMEBX (9.42). RMEBX return over 5 years is better than : 36.07 vs. OIERX (32.49).
OIERXRMEBXOIERX / RMEBX
Total Expense Ratio0.551.0751%
Annual Report Gross Expense Ratio0.551.0751%
Fund Existence15 years12 years-
Gain YTD14.8649.178162%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets44.2B117B38%
Annual Yield % from dividends1.471.00148%
Returns for 1 year12.259.42130%
Returns for 3 years33.6935.2696%
Returns for 5 years32.4936.0790%
Returns for 10 years133.2293.48143%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GREYX10.310.14
+1.38%
GuideStone Funds Global Rl Est Secs Inst
FSTSX19.070.22
+1.17%
Fidelity Series International Sm Cap
PWDCX11.990.13
+1.10%
DF Tactical Dividend Fund C
PTMAX24.19-0.05
-0.21%
PGIM Quant Solutions Large-Cap Cor Eq A
PACOX73.92-0.17
-0.23%
T. Rowe Price U.S. Equity Research Adv